Correlation Between Cingulate Warrants and FibroGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and FibroGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and FibroGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and FibroGen, you can compare the effects of market volatilities on Cingulate Warrants and FibroGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of FibroGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and FibroGen.

Diversification Opportunities for Cingulate Warrants and FibroGen

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Cingulate and FibroGen is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and FibroGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FibroGen and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with FibroGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FibroGen has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and FibroGen go up and down completely randomly.

Pair Corralation between Cingulate Warrants and FibroGen

Assuming the 90 days horizon Cingulate Warrants is expected to generate 3.12 times more return on investment than FibroGen. However, Cingulate Warrants is 3.12 times more volatile than FibroGen. It trades about 0.13 of its potential returns per unit of risk. FibroGen is currently generating about 0.18 per unit of risk. If you would invest  4.16  in Cingulate Warrants on September 5, 2024 and sell it today you would earn a total of  0.69  from holding Cingulate Warrants or generate 16.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Cingulate Warrants  vs.  FibroGen

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cingulate Warrants are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants showed solid returns over the last few months and may actually be approaching a breakup point.
FibroGen 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in FibroGen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, FibroGen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Cingulate Warrants and FibroGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and FibroGen

The main advantage of trading using opposite Cingulate Warrants and FibroGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, FibroGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will offset losses from the drop in FibroGen's long position.
The idea behind Cingulate Warrants and FibroGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world